KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Asset Writedowns and Impairment (2022 - 2025)

Historic Asset Writedowns and Impairment for Humana (HUM) over the last 4 years, with Q2 2025 value amounting to $32.0 million.

  • Humana's Asset Writedowns and Impairment changed N/A to $32.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $149.0 million, marking a year-over-year decrease of 2836.54%. This contributed to the annual value of $237.0 million for FY2024, which is 1504.85% up from last year.
  • Humana's Asset Writedowns and Impairment amounted to $32.0 million in Q2 2025.
  • In the past 5 years, Humana's Asset Writedowns and Impairment registered a high of $175.0 million during Q4 2023, and its lowest value of $4.0 million during Q3 2022.
  • In the last 4 years, Humana's Asset Writedowns and Impairment had a median value of $32.5 million in 2024 and averaged $62.0 million.
  • As far as peak fluctuations go, Humana's Asset Writedowns and Impairment skyrocketed by 67500.0% in 2023, and later crashed by 7272.73% in 2025.
  • Over the past 4 years, Humana's Asset Writedowns and Impairment (Quarter) stood at $104.0 million in 2022, then surged by 68.27% to $175.0 million in 2023, then crashed by 38.29% to $108.0 million in 2024, then plummeted by 70.37% to $32.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $32.0 million for Q2 2025, versus $9.0 million for Q1 2025 and $108.0 million for Q4 2024.